Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxygen Therapy in Diabetic Kidney Disease
NCT06959485Not yet recruiting
- Sponsor
- Assiut University
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Randomised, open-label trial of oxygen in diabetic kidney disease (DKD) (4 arms), sponsored by Assiut University. Primary endpoint: Improving of proteinuria in diabetic kidney disease at 6 months. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
oxygen
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT06959485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06959485.